Back to top

MDGL Maintained by Barclays -- Price Target Lowered to $962

MDGL Maintained by Barclays -- Price Target Lowered to $962

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Madrigal Pharmaceuticals, Inc. (MDGL)